- Home
- QUAD vs OLMA Comparison
QUAD vs OLMA Comparison
Compare QUAD & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUAD
- OLMA
- Stock Information
- Founded
- QUAD 1971
- OLMA 2006
- Country
- QUAD United States
- OLMA United States
- Employees
- QUAD N/A
- OLMA N/A
- Industry
- QUAD Publishing
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- QUAD Consumer Discretionary
- OLMA Health Care
- Exchange
- QUAD Nasdaq
- OLMA Nasdaq
- Market Cap
- QUAD 287.7M
- OLMA 289.0M
- IPO Year
- QUAD 2010
- OLMA 2020
- Fundamental
- Price
- QUAD $5.53
- OLMA $3.34
- Analyst Decision
- QUAD Strong Buy
- OLMA Strong Buy
- Analyst Count
- QUAD 2
- OLMA 4
- Target Price
- QUAD $10.15
- OLMA $26.75
- AVG Volume (30 Days)
- QUAD 223.6K
- OLMA 906.8K
- Earning Date
- QUAD 04-29-2025
- OLMA 03-18-2025
- Dividend Yield
- QUAD 4.09%
- OLMA N/A
- EPS Growth
- QUAD N/A
- OLMA N/A
- EPS
- QUAD N/A
- OLMA N/A
- Revenue
- QUAD $2,672,200,000.00
- OLMA N/A
- Revenue This Year
- QUAD N/A
- OLMA N/A
- Revenue Next Year
- QUAD N/A
- OLMA N/A
- P/E Ratio
- QUAD N/A
- OLMA N/A
- Revenue Growth
- QUAD N/A
- OLMA N/A
- 52 Week Low
- QUAD $4.06
- OLMA $3.29
- 52 Week High
- QUAD $9.13
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- QUAD 42.51
- OLMA 24.94
- Support Level
- QUAD $5.29
- OLMA $3.93
- Resistance Level
- QUAD $5.58
- OLMA $4.26
- Average True Range (ATR)
- QUAD 0.16
- OLMA 0.32
- MACD
- QUAD 0.04
- OLMA -0.03
- Stochastic Oscillator
- QUAD 52.17
- OLMA 4.08
About QUAD Quad Graphics Inc
Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.